$50MSeries C, 3 March 2026
Funds US expansion and clinical studies of MRace in the USA, Europe and Australia.
- Amount
- $50M
- Stage
- Series C
- Announced
- 3 March 2026
- Lead
- DC Global Ventures
- Other investors
- Lumination Partners
- Use of funds
- Funds US expansion and clinical studies of MRace in the USA, Europe and Australia.
- Checked
- Announced by the company
- Source
- Polares Medical raises $50M Series C businesswire.com